儿科肠道细菌和病毒对SARS-CoV-2感染的反应
Antonia Piazzesi1, Stefania Pane2, Federica Del Chierico1
1Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Frontiers in cellular and infection microbiology
|February 6, 2024
概括
患有COVID-19的儿童具有独特的肠道细菌,可以保护他们免受严重疾病的影响. 这项研究分析了儿科患者的肠道微生物组和病毒组,揭示了保护性微生物特征和抗生素治疗的影响.
科学领域:
- 微生物学 微生物学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 儿童对SARS-CoV-2感染和严重的COVID-19进行部分保护.
- 肠道微生物组的免疫调节作用表明它可能会影响儿科COVID-19的结果.
- SARS-CoV-2 感染了肠道,使肠道微生物群成为疾病严重程度的潜在因素.
研究的目的:
- 为了研究小儿COVID-19患者的肠道细菌和病毒.
- 为了确定与儿童的保护或严重性相关的微生物特征.
- 评估抗生素治疗对儿科肠道微生物组和病毒组的影响.
主要方法:
- 枪支元基因组测序被用来描述肠道细菌体和病毒体.
- 患有SARS-CoV-2的儿科患者与年龄相匹配的健康对照进行了比较.
- 分析包括细菌,病毒,菌体和抗菌素耐药性基因的丰富性.
主要成果:
- 儿童COVID-19患者表现出明显的保护性细菌特征,与成人患者不同.
- 在COVID-19患者中观察到更高的便细胞巨乳病毒负载.
- 抗生素的使用改变了细菌体,病毒体和基因丰度 (抗菌素耐药性,毒性).
结论:
- 肠道微生物组在儿科COVID-19中发挥着重要作用,特定的细菌提供了保护.
- 这是第一个全面分析儿童COVID-19患者细菌组,病毒组和抗体组以及抗生素的影响的研究.
更多相关视频
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.4K
07:59Adapting Gastrointestinal Organoids for Pathogen Infection and Single Cell Sequencing under Biosafety Level 3 BSL-3 Conditions
Published on: September 10, 2021
3.1K
相关概念视频
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Microbiota of the Urogenital Tract
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
